ASCENTtandem diseasestentrieverADAPT
…eks to compare recanalization outcomes and procedural safety of ASCENT compared to thrombectomy with stentriever or ADAPT in an instit…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 257 of 2459FasudilAneurysmal subarachnoid hemorrhageDCZBrain Aneurysm FoundationstrokeNINDSaneurysmal SAHAmerican Heart AssociationGq-DREADDDCI+1 more
…n vessel lumen diameter and RBC flux in comparison to baseline. Fasudil treatment robustly rescues this contractile effect, with signif…
nBCAsubdural hematomalipiodolcSHDMMA embolizationcSDH
…an age of 75 years underwent MMA embolization with a mixture of nBCA and lipiodol (1:5). Twenty-three (23) patients underwent bilate…
Biffl grade 3 pseudoaneurysmspseudoaneurysmsantithrombotic therapystroke
…Introduction Management of Biffl grade 3 pseudoaneurysms varies across institutions. Guidelines recommend conservative m…
Onyx™ particlesSDHChronic subdural hematoma (cSDH)MMAeMiddle meningeal artery embolizationparticle embolizationstandalone coil embolization
…these, 62.0% were treated with standalone coils and 38.0 % with Onyx™ particles. In the coil cohort, the mean age was 71.3 years and 76.6% were…
tumor-related venous sinus stenosistumor-related sinus stenosistumor-related venous outflow obstructionsecondary intracranial hypertensionangioplastyPubMedEmbasetumor-related venous sinus obstructionWeb of ScienceTumors involving dural venous sinuses+2 more
…vement after reintervention.Conclusion Endovascular therapy for tumor-related venous sinus stenosis appears can lead to meaningful pressure reduction and symptomat…
mycotic aneurysmsarteriovenous malformationsvein of Galen malformationpseudoaneurysmsdistal intracranial pathologysmall distal aneurysmsaneurysmal subarachnoid hemorrhagedural arteriovenous fistulasKaneka Medical American-butyl cyanoacrylate
…Pathologies treated included arteriovenous malformations (n=2), mycotic aneurysms (n=2), aneurysmal subarachnoid hemorrhage (n=1), intracranial h…
Tigertriever-13ISCSNIS-2026DMVOESOCEQ-5DsICHFDAIV thrombolysis
… 0% (p=1), ITT, with 0 sICH in randomized patients treated with Tigertriever-13. The last patient 3-month follow-up will be completed in March …
sNPDRPRPpanretinal photocoagulationPDRmicroinvasive pars plana vitrectomyproliferative diabetic retinopathy
…8.66) dB in the PRP group (p=0.02).Conclusions In patients with sNPDR, PPV and PRP showed no significant difference in PDR progressio…
tofacitinibulcerative colitischronic pouchitisCTNNHMRC
…tinib on clinical biomarkers and quality of life; and safety of tofacitinib use for treatment of chronic pouchitis. Study period is up to t…
syphilisDoxycyclinechlamydiagonorrhoeaGCCTDoxyPEP
…0.74, p=0.003), CT (IRR 0.33, 95% CI 0.23 to 0.46, p<0.001) and syphilis (IRR 0.22, 95% CI 0.07 to 0.54, p=0.001), but not GC (IRR 0.89,…